Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia.
The presence of human papillomavirus (HPV) type 16 DNA in biopsies from precancerous lesions and from early lesions of human cervical cancer, and the integration of virus DNA into host cell DNA were analysed by dot blot and Southern blot hybridizations. HPV 16 DNA was detected in 23% of mild dysplasias, 32% of moderate dysplasias, 55% of severe dysplasias and 62% of carcinomas in situ by dot blot hybridization. Digestion of the DNA with restriction enzymes PstI and BamHI followed by Southern blot analysis revealed the presence of some typical restriction fragments of HPV 16 DNA in most virus-positive samples. In addition, we detected submolar fragments which might represent virus-cell junction sequences in 86% of dysplasias, suggesting that the integration of HPV 16 DNA could occur in the precancerous stage.
D002278:Carcinoma in Situ / Q000235:genetics / Q000382:microbiology; D004262:DNA Restriction Enzymes; D004279:DNA, Viral / Q000032:analysis* / Q000235:genetics; D005260:Female; D006801:Humans; D009693:Nucleic Acid Hybridization; D027383:Papillomaviridae / Q000235:genetics*; D011995:Recombination, Genetic; D002578:Uterine Cervical Dysplasia / Q000235:genetics / Q000382:microbiology*; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000382:microbiology
D004279:DNA, Viral; D004262:DNA Restriction Enzymes